R&D Costs and Pricing of Medicines and Health Technologies

[Kanaga Raja] The current model of medical innovation is ill-equipped to respond to the increasing emergence of infectious diseases amongst others, South Africa has underscored, in calling on WTO members to share their experiences of how TRIPS flexibilities have been used to address high prices and barriers on access to medical technologies and medicines.